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OBJECTIVE: The aim of the present study was to examine the probable relationship between the accumulation of oxLDL and 
hepatic fibrogenesis in cholestatic rats.
INTRODUCTION: There is growing evidence to support the current theories on how oxidative stress that results in lipid peroxi-
dation is involved in the pathogenesis of cholestatic liver injury and fibrogenesis. One of the major and early lipid peroxidation 
products, OxLDL, is thought to play complex roles in various immuno-inflammatory mechanisms. 
METHODS: A prolonged (21-day) experimental bile duct ligation was performed on Wistar-albino rats. Biochemical analysis of 
blood, histopathologic evaluation of liver, measurement of the concentration of malondialdehyde (MDA) and superoxide-dismutase 
(SOD) in liver tissue homogenates, and immunofluorescent staining for oxLDL in liver tissue was conducted in bile-duct ligated 
(n = 8) and sham-operated rats (n = 8). 
RESULTS: Significantly higher levels of MDA and lower concentrations of SOD were detected in jaundiced rats than in the sham-
operated rats. Positive oxLDL staining was also observed in liver tissue sections of jaundiced rats. Histopathological examination 
demonstrated that neither fibrosis nor other indications of hepatocellular injury were found in the sham-operated group, while 
features of severe hepatocellular injury, particularly fibrosis, were found in jaundiced rats. 
CONCLUSION: Our results support the finding that either oxLDLs are produced as an intermediate agent during exacerbated 
oxidative stress or they otherwise contribute to the various pathomechanisms underlying the process of liver fibrosis. Whatever the 
mechanism, it is clear that an association exists between elevated oxLDL levels and hepatocellular injury, particularly with fibrosis. 
Further studies are needed to evaluate the potential effects of oxLDLs on the progression of secondary biliary cirrhosis.
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INTRODUCTION
A prolonged obstruction of either the intra- or extra-
hepatic biliary duct may damage hepatic tissue and 
lead to the development of fibrosis and cirrhosis.1 Liver 
repair and fibrogenesis both resemble the wound healing 
process. Cirrhosis is an advanced stage of fibrosis that is 
characterized by the formation of regenerative nodules 
in the liver parenchyma separated by fibrotic septa. The 
generation of cirrhosis involves three major processes: cell 
death, aberrant extracellular matrix deposition (fibrosis), and 
vascular reorganization.2 Cholestasis is associated with, and 
probably best defined as, the impairment of bile formation. 
This impairment may be accompanied by or caused by the 
failure to excrete bile acids into the hepatocyte canaliculus, 
which disrupts the circulation of enterohepatic bile acid and 
elevates concentrations of hepatocellular and serum bile 
acid.3 
The impairment in hepatic regeneration in cholestatic 
livers is a well-known phenomenon that may be caused by 
altered hepatic hemodynamics (decreased portal venous 532
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flow), attenuated production of mediators that are associated 
with liver proliferation, increased rate of apoptosis, and 
blocked enterohepatic circulation. These processes are all 
induced by biliary obstruction,4 which reduces the portal 
venous flow and the production of liver growth-associated 
factors, increases hepatocyte apoptosis, and impairs 
enterohepatic circulation. All of these factors attenuate the 
hepatic regenerative capacity. The intrahepatic accumulation 
of toxic bile salts results in hepatocyte apoptosis via a 
Fas-dependent mechanism.5 Many toxic bile acids trigger 
oligomerization of the Fas death receptor, which, in turn, 
activates the classic Fas death receptor cascade.6 In addition, 
it has been shown that an increased expression of Toll-like 
receptor 2 and the Fas ligand in intrahepatic natural killer T 
cells after biliary obstruction is associated with hepatocyte 
apoptosis.7 These results indicate that biliary obstruction 
activates hepatocyte apoptosis. Bile acids may directly 
affect mitochondria, causing mitochondrial dysfunction 
and activating the mitochondrial pathway of cell death.8 
This information suggests that bile acids induce apoptosis 
in vitro.
Fibrosis is characteristic of chronic liver disease, 
irrespective of the underlying etiology. Hepatic stellate 
cells (HSCs) trigger pathogenesis by a liver damage-
dependent activation.9 Activated HSCs transdifferentiate into 
myofibroblasts (MFBs), which exhibit a synthesis profile that 
predisposes them to increased extracellular matrix (ECM) 
deposition. This process allows them to proliferate upon 
expression of mitogenic cytokines and their receptors, alters 
their morphology, and increases contractility by triggering 
α-αsmooth muscle actin (SMA) fiber formation. This then 
leads to the constriction of sinusoidal blood flow and 
increases the synthesis and release of fibrillar collagens.10 
Myofibroblasts do not normally exist in the liver. 
They are produced by the activation of HSCs and portal 
fibroblasts. Myofibroblasts (MFBs) derived from small 
portal vessels proliferate around biliary tracts in cholestasis-
induced liver fibrosis to initiate collagen deposition.11
Fibrosis develops with different spatial patterns according 
to the different prevalent mechanisms that are associated 
with the diverse causes of parenchymal damage. Indeed, 
fibrosis that is caused by chronic viral infection is initially 
concentrated within and around the portal tract, whereas 
fibrosis that occurs as a secondary effect of exposure to 
toxic/metabolic damage (as in bile duct obstruction) is 
located mainly in the centrolobular areas. Additionally, it 
is becoming increasingly evident that different cell types 
are involved in the deposition of the fibrillar extracellular 
matrix during active hepatic fibrogenesis. Hepatic stellate 
cells are mainly involved when hepatocellular damage is 
limited or concentrated within the liver lobule, whereas 
portal MFBs and fibroblasts contribute the most when the 
damage is located in the proximity of the portal tracts. In 
the later stages of evolution (septal fibrosis), it is likely that 
all extracellular matrix-producing cells will contribute to 
fibrogenesis.12 
The reduction of expression and function of transport 
systems is another crucial process that plays a key role in 
the pathogenesis of cholestasis and may cause or maintain 
cholestatic injury.13,14 Transport defects may be caused 
by hereditary genetic defects or acquired as a result of 
cholestatic injury, such as during inflammation, drug use, or 
biliary obstruction. It is also important to keep in mind that 
not all of the encountered changes in transporter expression 
are procholestatic and negative. While some of these 
alterations contribute to cholestasis, other changes might 
act as compensatory anticholestatic defense mechanisms, 
providing alternative excretory routes. Reducing basolateral 
bile acid uptake while simultaneously increasing basolateral 
bile acid excretion might be considered a major hepatic 
defense mechanism counteracting bile acid accumulation 
within hepatocytes.15 
With regard to the pathogenesis of cholestatic liver injury, 
the oxidative stress that is associated with increased lipid 
peroxidation is considered to be crucial for hepatotoxicity.16,17 
Lipid peroxidation, protein oxidation, and the thiol redox 
state of the cell are important indicators of oxidative stress.18 
Bile duct ligation causes changes in the equilibrium between 
the antioxidant and prooxidant activities; it favors the 
latter, as it increases production of free radicals and causes 
the reduction in free radical scavengers, such as catalase, 
superoxide dismutase, and glutathione peroxidase 19
The accumulation of hydrophobic bile acids impairs 
the mitochondrial electron transport chain and enhances 
the production of reactive oxygen species (ROS), which 
eventually disturb cellular energy homeostasis.20,21 Lipid 
peroxidation causes the depletion of mitochondrial 
respiratory chain elements, leading to a vicious cycle that 
results in more ROS generation.22
Lipids are known to be one of the major and consistent 
targets of oxidative stress.1 Studies on animals and humans 
have shown that there is a close relationship between lipid 
peroxidation and cholestatic liver injury.21,23 The role of 
lipid peroxidation products in the pathogenesis of excessive 
fibrogenesis in cholestasis has been, so far, the most 
investigated aspect of oxidative stress-induced damage. 
One of the major and early lipid peroxidation products 
to be identified was oxidized low-density-lipoprotein 
(oxLDL), which was first identified in large vessel walls 
when antioxidative protective pathways had failed; it was 
later popularized as a proatherogenic agent. Since then, 
oxLDL has been considered to be very important either in 533
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the initiation or perpetuation of atherosclerotic processes.24 
Following the identification of specific membrane receptors 
for oxLDL on Kupffer cells, HSCs, macrophages, and 
liver endothelial cells, we previously showed that oxLDL 
accumulates in the liver of bile duct-ligated BALB/c 
mice.25,26 Here, we used a prolonged (21-day) experimental 
bile duct ligation to examine the probable relationship 
between oxLDL accumulation and hepatic fibrogenesis in 
rat liver. 
MATERIALS AND METHODS
Animals: Sixteen male albino Wistar rats, weighing 
200-230 g, were used in the study. They were housed in 
stainless steel cages, under controlled temperature (23°C) 
and humidity with 12-hour dark/light cycles. They were 
maintained on a standard laboratory diet with tap water ad 
libitum throughout the experiment, except for an overnight 
fast before surgery. The experiments were carried out 
according to the guidelines set forth by the Ethics Committee 
of Zonguldak Karaelmas University, Zonguldak, Turkey.
Experimental Design: Animals were randomly divided 
into two groups of 8 rats each. Group I was designated as 
the prolonged obstructive jaundice group (OJ), while group 
II was established as the sham-operated group (SO). All 
surgical procedures were performed under strict sterile 
conditions, using intraperitoneal ketamine-HCl (Ketalar; 
Parke Davis, Morris Plains, NJ, USA) as the anesthetic 
agent (50 mg/kg bodyweight) and a standard upper midline 
incision. In group I, a bile duct ligation was carried out 
according to the method of Lee.27 In group II, the sham 
operation was performed by placing a silk ligature around 
the common bile duct and then removing it. The abdominal 
incision was closed in two layers with chromic 4–0 cat 
gut and 4–0 silk. The rats were allowed food and water ad 
libitum postoperatively. On the 21st day after the operation, 
blood samples of all animals were collected using the cardiac 
puncture method. Blood was centrifuged at 1,800 g for 15 
min at 4ºC to obtain plasma for biochemical analysis. After 
blood collection, the rats were killed and the livers of the 
animals were removed immediately for histopathological, 
immunofluorescent, and biochemical examination.
Biochemical analysis of blood: The serum bilirubin level 
was determined with Cobas Bio (Hoffman La Roche, Basel, 
Switzerland) using the bilirubin test (Hoffman La Roche). 
The serum activity of aspartate aminotransferase (AST), 
alanine aminotransferase (ALT), alkaline phosphatase (ALP), 
albumin, and gamma glutamine transpeptidase (GGT) was 
estimated using commercially available kits (Boehringer, 
Mannheim, Germany). Total protein concentration was 
measured according to the method described by Lowry et al, 
using serum bovine albumin as a standard.28
Malondialdehyde (MDA) and superoxide dismutase 
(SOD) measurement in liver tissue homogenate: The 
liver MDA level was assessed according to the method 
described by Ohkawa and Ohıshı.29 In brief, the liver 
was homogenized with cold 1.15% KCl to make a 10% 
homogenate. A solution of 0.2 ml of 8.1% SDS and 1.5 ml 
of 20% acetic acid was adjusted to pH 3.5 with NaOH, and 
1.5 ml of 0.8% aqueous solution of thiobarbituric acid was 
added to 0.2 ml of 10% tissue homogenates. The volume of 
the mixture was adjusted to 4.0 ml with distilled water, and 
then the mixture was heated in an oil bath at 95°C for 60 
min. After cooling with tap water, 1.0 ml of distilled water 
and 5.0 ml of a mixture of n-butanol and pyridine (15:1, v/v) 
were added, and the solution was shaken vigorously. After 
centrifugation at 4,000 rpm for 10 min, the organic layer 
was removed and its absorbance was measured at 532 nm 
on a Shimadzu UV 1601 spectrophotometer. As a standard, 
1.1.3.3-tetraetoxypropane was used. The MDA concentration 
was calculated per gram of tissue (nmol/gr tissue).
Hepatic SOD level was determined using the method of 
Sun et al.30 The assay for SOD activity involves inhibiting 
the reduction of nitroblue tetrazolium with xanthine and 
xanthine oxidase, which was used as a superoxide generator. 
Liver tissues were weighed, and 1.15% KCL was added to 
make a 10% homogenate. To 0.5 ml of the supernatant, 2.45 
ml SOD measurement reactive solution (40 ml 0.3 mmol/L 
xanthine, 20 ml 0.6 mmol/L EDTA, 20 ml 150 μmol/L 
nitroblue tetrazolium, 12 ml 400 mmol/L Na2CO3, and 6 ml 
1gr/L bovine serum albumin) was added. At 25°C, xanthine 
oxidase reagents were added in a volume of 0.05 ml per tube 
at 30 sec intervals and incubated for 20 min. The xanthine 
oxidase reagent was freshly prepared with ice-cold 2 mol/L 
NH4SO4; the final concentration of xanthine oxidase was 167 
U/L. Reactions were then terminated by adding 1 ml of 0.8 
mmol/L CuCl2 reagent into each tube at 30 sec intervals. 
The absorbance of each sample was measured at 560 nm 
on a Shimadzu UV 1601 spectrophotometer. The percent 
inhibition was calculated according to the formula: 
% inhibition= [(A blank – A sample)/A blank] x 100
One unit of SOD is defined as the amount of protein that 
inhibits the rate of NBT reduction by 50%. SOD activity was 
calculated per mg of tissue protein (U/mg protein).
Immunofluorescence staining of the rat liver tissue: 
The presence of oxLDL in the liver tissue sections of the 
jaundiced and the sham-operated rats was evaluated using 
a special method of immunofluorescence staining. The 534
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left lobe of each rat liver was obtained and stored at -85°C 
in a deep freezer. The slides were prepared from frozen 
liver biopsy sections, which were cut to a thickness of 7 
μm. Slides were further divided into two pieces: one was 
used for the test, and the other was used as a negative 
control. Primary antibody in 30 μl (human polyclonal 
anti-oxLDL immunoglobulin (Ig)G, IMMCO Diagnostics, 
New York, NY, USA) was added only to the test slides, 
wheras phosphate buffered solution (PBS) in the same 
volume was added to the control slides. After incubating 
for 30 min in a humid chamber at room temperature, both 
the control and test slides were washed with PBS, and a 
fluorescein isothiocyanate labeled antihuman IgG (30 μl) 
was administered as a conjugate substance. After another 30 
min at room temperature, the slides were washed with the 
standard PBS solution. After drying, the slides were covered 
with a mounting medium and examined under a fluorescence 
microscope (Leica DMRX, Wetzlar, Germany). 
Histopathological evaluation: For  histological 
examination, tissue samples from the liver were obtained 
from all animals. The liver samples were fixed in 10% 
neutral buffered formalin, embedded in paraffin, sectioned 
at 5 μm, and stained with hematoxylin and eosin. A single 
pathologist, blind to the study, assessed all biopsies. 
Although we acknowledge that there are differences in the 
pathogenesis of cholestasis cases caused by obstruction 
and hepatocellular lesions caused by chronic hepatitis, we 
have herein evaluated a scoring system following the same 
categorization as described by Ishak et al. in order to provide 
semi-quantitative scores to assess the degree of inflammatory 
activity and fibrosis.31 Liver damage was categorized as 
mild, moderate, or severe (cirrhosis). Inflammatory scores 
between 1-3 and fibrosis scores between 1-2 were classified 
as mild; inflammatory scores between 4-18 and fibrosis 
scores between 3-5 were classified as moderate liver damage. 
Cirrhosis was considered to be a fibrosis score of 6. 
Statistical analysis: Data are expressed as mean ± SD. 
Comparisons among the groups were performed using 
the Mann-Whitney U test. Differences were considered 
significant when p < 0.05.
RESULTS
No deaths were observed in groups I or II. All animals 
with bile duct ligation were obviously jaundiced by 5-6 days 
after the operation. The jaundice was confirmed by assessing 
serum bilirubin concentration on the 21st day after bile duct 
ligation. 
The mean values of the serum AST, ALT, ALP, GGT, 
total protein, bilirubin, and albumin concentrations measured 
in the blood samples are presented in Table 1. Prolonged 
obstructive jaundice significantly increased the serum AST, 
ALT, ALP, GGT, and bilirubin concentrations as expected. 
While there were no statistically significant differences 
between groups in serum total protein concentration, serum 
albumin concentrations were significantly decreased in 
prolonged obstructive jaundiced animals. 
The mean MDA and SOD activities of the livers in each 
group are shown in Table 2. While the mean liver content of 
SOD in group I was significantly lower than that of group II, 
prolonged bile-duct ligation resulted in a significant increase 
in the liver MDA content as compared to sham-operated rats 
(Table 2). 
A significant positive immunofluorescence staining 
for oxLDL was found in the liver tissue sections of the 
prolonged jaundiced group (group I; Figure 1), and we did 
not observe any positive immunofluorescence staining in 
sham-operated rats (group II; Figure 2).
Histopathological sections obtained from the liver tissues 
were examined under a light microscope. The evaluation of 
the above-mentioned criteria was performed by the same 
histopathologist. Neither fibrosis nor any of the other criteria 
Table 1 - Mean values of the serum biochemical analysis 
Group Albumin (g/dl) ALP (U/L) ALT (U/L) AST (U/L) Bilirubin (mg/dl) TP (g/dl) GGT (U/L)
1 (n=8) 2,84±0,41* 254,73±36,23* 107,75±34,89* 452,38±148,15* 10,35±3,82* 7,48±0,60 28,9±27,77*
2 (n=8) 3,74±0.53 187,90±43,36 64,38±15,77 199,13±58,20 0,47±0,17 7,39±0,25 0,95±0,76
*p < 0.05 using Mann-Whitney U test. Values are mean ± SD; Group 1: prolonged obstructive jaundiced group. Group 2: sham-operated rats. Serum ALP, ALT, 
AST, GGT, and bilirubin levels were determined to be significantly increased in group I, whereas albumin level was found to be significantly decreased.
Table 2 - Mean liver MDA and SOD concentrations in the 
prolonged obstructive jaundiced and sham-operated rats
Group MDA (nmol/gr liver) SOD (U/mg protein)
1 (n=8) 35.07±3.73* 1.62±1.36*
2 (n=8) 20.86±4.69 7.86±1.42
*p < 0.01 using Mann-Whitney U test. Values are mean ± SD; Group 1: 
prolonged obstructive jaundice group. Group 2: sham-operated rats. Twenty-
one days of biliary obstruction causes a significant increase in MDA level, 
while hepatic SOD concentration was significantly lower in group 1 than 
in group 2.535
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for inflammation and hepatocellular injury were observed in 
the sham-operated group, whereas features of severe hepatic 
injury, namely fibrosis, were determined in the liver tissues 
of prolonged obstructive jaundiced rats (Figures 3-4). Table 
3 displays the histological evaluation. 
DISCUSSION
Obstructive jaundice leads to hepatocellular injury and 
causes many systemic complications. Irrespective of the 
etiology, liver fibrosis is a common consequence of chronic 
liver injury.32 Liver fibrosis is defined as the abnormal 
accumulation of extracellular matrix in the liver. Its endpoint 
is cirrhosis, which is responsible for significant morbidity 
and mortality. 
Recently, hereditary defects in the hepatobiliary transporter 
have been shown to cause cholestasis. Cholestasis may result 
either from a functional defect in bile formation at the level of 
the hepatocyte or from an impairment in the secretion of bile 
and/or obstruction of flow at the bile duct level.33 
Hepatic uptake and biliary excretion of organic anions, 
such as bile acids and bilirubin, is mediated by hepatobiliary 
transport systems. Defects in transporter expression and 
function may cause or maintain cholestasis and jaundice. The 
recruitment of alternative export transporters in coordination 
with phase I and II detoxifying pathways provides alternative 
elimination pathways to counteract the accumulation of 
potentially toxic biliary constituents in cholestasis.32 The 
genes encoding for organic anion uptake (NTCP/SLC10A1, 
Figure 1 - A significant positive immunofluorescent staining for oxLDL in 
liver tissue sections of the prolonged jaundiced group of rats.
Figure 2 - There is no positive immunofluorescent staining for oxLDL in 
sham-operated rats
Figure 3 - Normal histological features of the liver in sham-operated rats
Figure 4 - Severe hepatic injury and fibrosis in the prolonged obstructive 
jaundiced group of rats536
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OATPs), canalicular export (BSEP, MRP2), and alternative 
basolateral export (MRP3, MRP4) transporters in the 
liver are regulated by a complex interacting network of 
hepatocyte nuclear factors (HNF1, 3 and 4) and nuclear 
receptors (e.g., FXR, PXR, CAR, RAR, LRH-1, SHP, and 
GR).34 Moreover, adaptive transporter changes, such as the 
induction of basolateral efflux pumps, may help to limit 
hepatic accumulation of potentially toxic biliary constituents 
in cholestasis by providing alternative escape routes.33 Bile 
acids, proinflammatory cytokines, hormones, and drugs 
mediate these causative and adaptive transporter changes 
at a transcriptional level by interacting with these nuclear 
factors and receptors. 
Increased matrix formation (i.e., fibrogenesis) occurs in 
parallel to decreased matrix degradation (i.e., fibrolysis). A 
landmark finding was the identification of activated HSCs 
and MFBs as the major collagen-producing cells, which, 
upon activation by profibrogenic cytokines, acquire a 
profibrogenic phenotype and start to synthesize extracellular 
matrix that replaces parenchymal tissue.35 The progression 
of fibrosis results in the development of cirrhosis, chronic 
liver failure, portal hypertension, and hepatocellular 
carcinoma.31,36 
As fibrosis develops in response to liver injury, HSC 
activation leads to the accumulation of a scar matrix. 
This process, in turn, contributes to the loss of hepatocyte 
microvilli and endothelial fenestrae, leading to the 
deterioration of hepatic function. Kupffer cell (macrophage) 
activation contributes to the activation of HSCs.37 In the 
cholestatic rodent, Kupffer cell activation and the infiltration 
of neutrophils contribute to tissue injury.38 Similarly, in our 
experimental data, neutrophil infiltration was evident in bile 
duct-ligated rats but not in sham-operated rats. 
Activated HSCs, portal fibroblasts, and MFBs of bone 
marrow origin have been identified as the major collagen-
producing cells in the injured liver. These cells are activated 
by fibrogenic cytokines, such as angiotensin II, TGF-α1, and 
leptin. 39
Recent reports have highlighted the important role of 
bile in maintaining intestinal integrity and normal intestinal 
immunity.40 The impaired function of the intestinal barrier 
in patients with biliary obstruction is restored by bile 
replacement.41 Bile administration maintains the integrity and 
permeability of the intestinal mucosa and prevents villous 
atrophy, villous edema, and lacteal canal dilation. These 
results were obtained using rats with biliary obstruction.43 
The lack of enterohepatic circulation during biliary 
obstruction also affects hepatic regeneration. The excretion 
rates of biliary lipids are disturbed with external biliary 
drainage compared to rates with internal biliary drainage, 
and liver regeneration rate is significantly correlated with bile 
flow and the excretion rates of biliary lipids.44 These results 
clearly indicate that the lack of enterohepatic circulation 
in the cholestatic liver is one of the major contributors to 
impaired hepatic regeneration.4 
One of the most interesting targets of experimental 
investigation that has been undertaken so far has been the 
mechanism underlying cholestatic liver damage. Liver 
fibrosis is a complex phenomenon, in which nonparenchymal 
cells, such as Kupffer cells and HSCs, are reported to play a 
major role.45 Kupffer cells stimulate the progression of the 
fibrogenic process and HSCs synthesize most of the matrix 
proteins. Hepatic fibrosis develops 2-3 weeks after bile 
duct ligation in rats; this was the length of our experimental 
period. Mitochondrial oxidative stress and lipid peroxidation 
are considered to be the significant molecular players 
in cholestatic liver injury.46 A increase in oxidative over 
antioxidative biochemical activities, (i.e., during oxidative 
stress), has been reported to occur in liver fibrosis.1 Since 
lipids are a major target of oxidative stress, products of 
lipid peroxidation seem to play a role in cholestatic liver 
Table 3 - Histological activation index modified by Ishak 
et al. 
GRADE: Necroinflammatory score (0-18) STAGE: 
Fibrosis 
score 
(0-6)
Peri-
portal/
periseptal 
interface 
hepatitis 
Confluent 
necrosis 
Focal 
lytic 
necrosis, 
apopito-
sis, focal 
inflam-
mation
Portal 
inflam-
mation 
Fibrosis 
OJ-1 3 1 1 2 4
OJ-2 3 2 2 3 3
OJ-3 3 3 2 3 3
OJ-4 3 3 2 4 4
OJ-5 3 2 3 3 3
OJ-6 3 2 2 2 4
0J-7 3 2 2 3 4
OJ-8 2 3 2 2 3
SO-1 0 0 0 0 0
SO-2 0 0 0 0 0
SO-3 0 0 0 0 0
SO-4 0 0 0 0 0
SO-5 0 0 0 0 0
SO-6 0 0 0 1 0
SO-7 0 0 0 0 0
SO-8 0 0 0 0 0
OJ = obstructive jaundiced rat; SO = sham-operated rat537
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injury. The extent of oxidative stress is thought to be a 
crucial factor determining various pathophysiological 
conditions, with the spectrum of conditions ranging from 
cell modulation to fibrosis, to inflammation, irreversible cell 
damage, and apoptosis.45 It has been observed that in chronic 
cholestasis, an increased concentration of biliary acids in 
hepatocytes induces mitochondrial toxicity and results in 
the overproduction of ROS.47 Furthermore, increased lipid 
peroxidation has been reported to occur in the model of 
bile duct ligation.48 A statistically significant correlation 
between total bilirubin levels and lipid peroxidation has 
also been described in hepatic toxicity and diseases of the 
biliary tract.49 The observation of increased lipid peroxide 
levels in the blood of children with chronic cholestasis 
supports the oxidative hypothesis and explains, at least in 
part, the cholestatic-induced hepatocellular injury.50 Sokol 
et al. has also shown that exposure to hydrophobic bile acids 
causes a significant peroxidation of membrane lipids in 
isolated hepatocytes and liver mitochondria.51 In obstructive 
jaundice, increased hepatic lipid peroxidation, hepatocellular 
mitochondrial dysfunction, and decreased glutathione levels 
occur.52
Previous reports have shown that bile duct ligation in the 
rat for four weeks produces cirrhosis and a sixfold increase in 
liver collagen content.53 If the large biliary duct is obstructed 
for several weeks to months, as in our experiment, cholestasis 
extends throughout the lobule and hepatocyte necrosis leads 
to lobular bile infarcts. The ductular reaction develops at 
the periphery of the portal tracts and extends toward the 
neighboring portal tracts and deep into the parenchyma. 
This ductular reaction is accompanied by the proliferation of 
periductular (myo)fibroblasts that are derived from the portal 
fibroblasts around the interlobular bile ducts. Extensive 
fibrosis surrounding the ductular reaction enlarges the portal 
tracts and leads to the formation of porto-portal septa.2 In the 
septa development process of portal fibrogenesis, researchers 
maintain that viral hepatitis leads to the formation of 
porto-central septa, featuring activation of HSC, and that 
cholestatic liver diseases lead to portal–portal septa laid 
down by portal-tract-derived mesenchymal cells.54 
During cirrhosis, the normal architecture of the liver is 
completely modified by the development of fibrotic septa. 
The cell populations involved differ according to their pattern 
of fibrosis. In portal diseases, such as chronic viral hepatitis 
and chronic bile duct obstruction, portal fibroblasts are found 
in the septa and HSCs are found at the interface between the 
septa and parenchyma.2 In the model of cholestatic fibrosis 
induced by common bile duct ligation, the withdrawal of 
intraductal pressure is sufficient to induce apoptosis in bile 
duct epithelial and portal fibroblastic cells, and to elicit 
extracellular matrix remodeling.55 These data provide insight 
into the mechanisms involved in the regression of cholestatic 
diseases and highlight the role of mechanical stimuli in cell 
growth and death.
The experimental bile duct ligation in rats, as in our 
experiment, is still one of the main models that support a link 
between oxidative damage and fibrogenesis during chronic 
cholestasis, which mimics clinical and morphological aspects 
of fibrosis and cirrhosis secondary to extrahepatic biliary 
obstruction in humans. We used 21 days of obstructive 
jaundice, as the collagen deposition was reported to 
become significant only after 15 days of bile duct ligation.23 
The histopathological evaluation of liver tissue from the 
jaundiced group exhibited marked features of hepatocellular 
injury and fibrosis. In bile duct-ligated rats, the presence of 
marked oxidative stress and oxidative damage to lipids is 
traditionally demonstrated with thiobarbituric acid (TBA) 
reactive substance assays, which detect MDA, a peroxidation 
product of polyunsaturated fatty acids.56 MDA is considered 
to be the major product of lipid peroxidation.57 An MDA 
assay is generally used to detect the existence of lipid 
peroxidation as a result of oxidative stress in any tissue. In 
our study, we found that 21 days of obstructive jaundice 
resulted in a significant elevation of the concentration of 
liver MDA, compared with the sham-operated group (35.07 
± 3.73 vs. 20.86 ± 4.69 nmol/gr liver, p < 0.01; Table 2). This 
result is also in agreement with other studies on obstructive 
jaundice conducted in animals and humans.20 Moreover, the 
level of the antioxidant enzyme SOD, which is the scavenger 
of ROS in oxidative stress, was found to be significantly 
reduced in the jaundiced group (1.62 ± 1.36 vs. 7.86 ± 1.42 
nmol/gr liver, p < 0.01; Table 2).
One of the major and early lipid peroxidation products 
is oxLDL. As the unsaturated fatty acids oxidize, they 
undergo molecular rearrangements and generate peroxy-
fatty acids. These readily decompose, particularly in the 
presence of redox metals, such as iron and copper, to 
generate aldehydes, such as MDA, 4-hydroxynonenal, and 
others.58 During oxidative stress, plasma LDL is oxidatively 
modified mainly in the subendothelial space, attracting blood 
monocytes to the subendothelial spaces. These monocytes 
differentiate into macrophages, which further contribute 
to LDL oxidation. OxLDL is taken up by macrophages 
via scavenger receptors.59 These scavenger receptors have 
been shown to exist in many cells, including Kupffer cells, 
HSCs, macrophages, and liver endothelial cells.1,25,60 These 
phagocytic cells are reportedly responsible for a marked 
increase in the steady-state concentration of fibrogenic 
cytokines that intensify the cross-talk with extracellular 
matrix-producing cells.1 The liver is the primary organ for 
the clearance of the oxidatively modified cytotoxic and 
atherogenic LDL molecules. The effective filtration of 538
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oxLDL has been confirmed by the complete removal of 
these molecules from circulation within a few minutes when 
administered exogenously.60 Fluorescently-labeled oxLDL 
was essentially found to concentrate in Kupffer cells and, 
to a lesser extent, in endothelial cells in humans and in the 
rat liver. Following the rapid hydrolysis of cholesteryl esters 
from oxLDL by Kupffer cells, the molecule is transported 
to liver parenchymal cells and bile.61 Complete bile duct 
ligation may preclude the residual oxLDL transfer to the bile. 
Therefore, it is expected that oxLDL would accumulate in 
the liver after bile duct ligation. Previously, we have shown, 
using fluorescent immunostaining, that oxLDL accumulates 
in the liver of BALB/c mice after 10 days of experimental 
cholestasis.26 In this study, we used a prolonged period of 
obstructive jaundice, 21 days, as ıt has been demonstrated 
that, at high degrees of oxidation of LDL, the affinity for the 
oxLDL specific binding site is strongly enhanced and the 
phagocytic capacity of Kupffer cells increases within 2-3 
weeks of biliary obstruction.62 Ongoing oxidative stress in 
prolonged cholestasis induces more ROS production than 
usual, which may enhance the oxidative modification of 
LDL within the liver. Free radicals not only induce oxidative 
stress in the liver but also initiate and maintain the oxidation 
of LDL.63 It has been demonstrated that there is a close 
relationship between the severity of fibrosis and the amount 
of lipid peroxidation products, which reflects the level of 
oxidative stress.64 Moreover, there is a close link between 
lipid peroxidation and the activation of inflammatory cells, 
and a positive linear correlation exists between collagen 
deposition and the production of MDA.23 Our results 
related to the MDA concentration are in agreement with the 
literature.23,64
Independently from the nature of the injury, the 
fibrogenic pathway is similar in various tissues. Kupffer 
cells and HSCs are the key players in liver fibrosis. The 
phenotypic transformation of HSCs into MFB-like cells is 
considered to be the central event of hepatic fibrogenesis. 
The activation of HSCs results in the production of a large 
quantity of extracellular matrix components. In an in vitro 
study, it was shown that there were specific receptors 
for oxLDL in HSCs that stimulate the synthesis of the 
extracellular matrix, a result that is consistent with the 
hypothesis that oxLDL might at least participate in the events 
leading to liver inflammation and fibrosis in cholestasis.25
In conclusion, we have demonstrated that oxLDL 
accumulates in liver tissue sections of prolonged obstructive 
jaundiced rats. Furthermore, we show that there is significant 
hepatic fibrosis evident upon histopathological examination. 
The accumulation of oxLDL may be the consequence of 
either a failure to eliminate it via bile flow or a cholestasis-
induced enhancement of ROS production and lipid 
peroxidation, which may predict ongoing oxidative stress. 
Oxidative damage, possibly in association with more than 
one mechanism, appears to be crucial for the progression 
of fibrosis through cirrhosis in cholestatic liver injury. We 
believe that oxLDL might at least play a contributory role in 
the various pathophysiological mechanisms underlying the 
process of liver fibrosis and that the association of oxLDL 
accumulation and hepatic fibrosis deserves to be considered 
as something more than coincidence in cholestasis. Further 
studies are needed to evaluate the potential effects of oxLDL 
in the progression to secondary biliary cirrhosis.
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